Dynamic Duo Seminar Series: "Response and Resistance to targeted inhibitors in melanoma"
Berger presentation overview:
- Melanoma epidemic
- Survival Statistics
- Sentinel node biopsy/MSLT-1
- Targeted therapy
Future Directions/Translational Work
Dr. Aplin's presentation is titled:
- Response and resistance to targeted therapies in melanoma
End of presentation continues here (last 06:73)
Recommended CitationBerger, MD, FACS, Adam C. and Aplin, PhD, Andrew E., "Dynamic Duo Seminar Series: "Response and Resistance to targeted inhibitors in melanoma"" (2016). Department of Surgery, Grand Rounds. Presentation 85.